Yes, am also sitting tight. This is a lot like December 2011.
I don't expect a lot from Jan sales - probably decent given VAST improvement in DRAM. Feb customarily slow given fewer working days and Chinese New Year. We should be off to the races in March with a HUGE m/m improvement.
We probably sit at $10.50-$11.50 for a while, but catalysts include:
1. Taiwan listing
2. Cowen coverage
3. M/M improvement (that's probably a couple months away).
Jaret and I have been spending a lot of time on the NTE board - at this point it's as cheap as IMOS, has better growth prospects, pays almost a 5% dividend, and has a real estate asset that is conceivably worth more than the entire market cap. It has no research coverage, but we both think it's coming in the next few months. It could be like IMOS' move last year from $5 to $15. We think at these levels it could go much higher, potentially very quickly.